Active MRSA surveillance testing in about an hour
Norovirus is a highly contagious virus and is the most common cause of viral gastroenteritis worldwide. Globally, the virus affects approximately 267 million people and causes over 200,000 deaths each year.2
- Norovirus outbreaks in healthcare institutions require immediate implementation of infection control measures to avoid ward closures
- Patients with acute diarrhea should be placed into isolation until proven non-infectious3
- The ease of Norovirus transmission, with a very low infectious dose of 10–100 virions, short incubation period (24–48 hours), and lack of durable immunity, enables Norovirus to spread rapidly4
Controlling a Norovirus outbreak requires a fast, accurate and easy-to-use test that detects Noroviruses of genogroup I (GI) and genogroup II (GII), which are responsible for the majority of infections.
Xpert® Norovirus delivers:
- Fast and accurate identification of Norovirus GI & GII in as little as one hour*
- Actionable results for clinicians when it is needed most
- Laboratory efficiencies with on-demand workflows requiring minimal hands-on time
- Timely infection control initiatives to reduce the spread of infection
- Optimized management of isolation beds for improved patient management and reduced costs
Fast and accurate PCR testing with Xpert® Norovirus greatly improves time to result, allowing healthcare professionals to quickly identify, isolate and appropriately manage patients, helping prevent spread.
Improve Workflow and Patient Management5
- Deliver actionable results, across laboratory and POC, to clinicians in as little as one hour*
- On-demand and STAT testing removes the need for batching, providing results 24/7
- Ease of use and minimal hands-on-time enables more efficient use of staff time
Impact on Patient Pathway: "Test and Treat"
* with EAT (Early Assay Termination), for positive results. Reporting negative results in 90 minutes.
^ See Xpert Norovirus Product Insert (301-2440, Rev. F May 2020) for additional details.
(1) Cleary O, et al. Evaluation of the Xpert Norovirus assay for the rapid detection of norovirus genogroups I and II in faecal specimens within a routine laboratory setting. British Journal of Biomedical Science. 2017 Dec:74(3):144-147.
(2) Rovida F, et al. Evaluation of Xpert Norovirus Assay performance in comparison with real-time RT-PCR in hospitalized adult patients with acute gastroenteritis. Diagn Microbiol Infect Dis. 2016 Aug;85(4):426-427
(3) Gonzalez M, et al. Multicenter evaluation of the Xpert Norovirus assay for detection of norovirus genogroups I and II in fecal specimens. Journal of Clinical Microbiology. 2015 Dec;54(1):142-147
(4) CDC. 2015. Norovirus Guidelines for Healthcare Settings: Background. Accessed May 2021. https://www.cdc.gov/infectioncontrol/guidelines/norovirus/background.html
(5) Dewar S, et al. Point-of-care testing by healthcare workers for detection of meticillin-resistant Staphylococcus aureus, Clostridioides difficile, and norovirus. 2019 Aug;103(4):447-453
Number of Tests: 10Catalog #: GXNOV-CE-10